| Literature DB >> 32580329 |
Rashita Makkar1, Tapan Behl1, Simona Bungau2, Gokhan Zengin3, Vineet Mehta4, Arun Kumar1, Md Sahab Uddin5,6, Ghulam Md Ashraf7,8, Mohamed M Abdel-Daim9, Sandeep Arora1, Roxana Oancea10.
Abstract
Neurological diseases are one of the major healthcare issues worldwide. Posed lifestyle changes are associated with drastically increased risk of chronic illness and diseases, posing a substantial healthcare and financial burden to society globally. Researchers aim to provide fine treatment for ailing disorders with minimal exposed side effects. In recent decades, several studies on functional foods have been initiated to obtain foods that have fewer side effects and increased therapeutic activity. Hence, an attempt has been made to unravel several extraction techniques to acquire essential bioactive compounds or phytochemicals from therapeutically active food products. This has led to the conception of the term functional foods being meddled with other similar terms like "pharmafoods," "medifoods", "vitafoods", or "medicinal foods". With a dire need to adhere towards healthy options, the demand of nutraceuticals is widely increasing to combat neurological interventions. An association between food habits and the individual lifestyle with neurodegeneration has been manifested, thereby proposing the role of nutraceuticals as prophylactic treatment for neurological interventions. The current review covers some of the major neurological disorders and nutraceutical therapy in the prevention of disease.Entities:
Keywords: food supplements; herbal therapeutics; neurodegeneration; neurological disorders; nutraceuticals
Mesh:
Substances:
Year: 2020 PMID: 32580329 PMCID: PMC7352709 DOI: 10.3390/ijms21124424
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Some of the most commonly used nutraceuticals that can be employed as adjunctive therapy in the management of neurological degeneration, Parkinson’s disease, depression, Alzheimer’s disease, and psychosis simultaneously [1,2,4].
Figure 2Summarized pathogenesis of misfolded proteins and neurodegeneration mediated upon their activation. The misfolded proteins lead to the activation of cascade of inflammatory proteins, such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), inducible nitric oxide synthase (iNOS), and cyclooxygenase (COX), and activation of interleukins and inflammatory cytokines, which leads to inflammation and further neurodegeneration. Inhibition of these cascade proteins by active nutraceuticals tends to provide neuroprotective action.
Figure 3Nutraceuticals in Parkinson’s disease act by three pathways. 1. By preventing oxidative stress, which leads to protection of mitochondria from further damage and dysfunction and ultimately maintains energy homeostasis and cellular metabolism; 2. Activation of misfolded proteins and their aggregation induces stress in endoplasmic reticulum (ER), which further causes autophagy and degradation of neuronal proteins. 3. Inflammation in neuronal cells is the main cause of neurodegeneration and onset of Parkinson’s disease [77,78,79,80].
Some of the commonly employed nutraceuticals in the management of depression as an adjunctive therapy, which thereby present a curative approach [82,83].
| Compound | Mechanism of Action |
|---|---|
|
| They act by inhibiting re-uptake of monoamines during neurological transmission and benefits neurotransmission by increasing the fluidity in membranes of cell. These molecules decrease inflammatory mediators and their synthesis, enhancing neurogenesis and prevents depressive episodes [ |
|
| It mainly comprises of anti-inflammatory and antioxidant activities which leads to replenishment of glutathione levels and enhances neurogenesis. It also protects the individual against mitochondrial toxicity and modulates glutamate pathway thereby preventing depression. |
|
| It mainly influences the production and biotransformation of neurotransmitters as it is an important methyl donor of methyl groups. It also decreases the secretion of prolactin and increases the conversion of phosphatidylcholine [ |
|
| Tryptophan is required for conversion into serotonin in the presence of B6 and magnesium to actively form 5-HTP through intermediate processes. The augmentation of tryptophan with a range of antidepressants has been found to be effective in increasing effect. It is used in concert with a range of antidepressants, protein deficient, or in patients with dysregulated serotonergic pathways. |
|
| Vitamin D is a ‘neurosteroid’ compound that acts as a ligand for receptors that are present in the hypothalamus, substantia nigra and prefrontal cortex region of the brain. It chiefly regulates the genetic expression leading to coding of protein tyrosine hydroxylase. |
|
| Zinc is the most predominant trace element found in the hippocampus, amygdala and neocortex regions of the brain. It mainly leads to amplification of neurogenesis in hippocampal regions by increasing BNDF. The activity of glutamate and NMDA receptors is also modified. |
Summary of the nutraceuticals discussed in the current review with their mode of action and specific disease activity [64,82,83].
| Disease | Mechanism of Action and Commonly Used Nutraceuticals |
|---|---|
|
| Neurodegenerative disorders are mainly developed by protein misfolding. Nutraceuticals mainly prevent misfolding of proteins by inhibiting the activation and synthesis of proinflammatory cytokines and associated pathways.Example: bacoside A, bacoside B, brahmine, quercetin, kaempferol, withanine, somniferine, asiatic acid, bhilavanol A and B. |
|
| AD is mainly associated with increase in oxidative stress and free radicals. The nutraceuticals typically antioxidant in nature are mostly employed in the management of this disease. Examples: flavonoids (fruits, vegetables, tea, wine, coffee); carotenoids (lutein, zeaxanthin, lycopene, β-cryptoxanthin including α and β carotenes); anthocyanidins (cyanidin); flavones (luteolin, apigenin). |
|
| The uninhibited oxidative stress and free radicals in association with abnormally misfolded proteins, neuroinflammation, and dysfunctional mitochondria lead to compromised cellular metabolism and energy thereby impacting the functioning of the brain and leading to neurodegenerative disorders including PD.Examples: Vitamin A, Omega-3 fatty acids, lycopene, vincamine, gallic acid, curcumin, Mito Q. |
|
| Nutraceuticals that act by inhibiting re-uptake of monoamines, possess anti-inflammatory and antioxidant properties which are well suited for management of depression.Examples: Omega-3 fatty acids, folic acid, S-adenosyl methionine, zinc, N-acetyl cysteine, L-Tryptophan/5-HTP, Vitamin-D. |
|
| Nutraceuticals that can improve neurotransmission in dopaminergic serotoninergic neurons can be employed in management of psychosis. These mainly includes all types of vitamins and omega 3 fatty acids. |